Cited by

• Pharmacologic Options for Prevention and Management of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage.

  Kiser TH. Kiser TH. Hosp Pharm. 2013 Sep;48(5 Suppl):S2-S9. doi: 10.1310/hpj48S5-S2. Epub 2013 Sep 1. Hosp Pharm. 2013. PMID: 35694374 Free PMC article.
• Management of aneurysmal subarachnoid hemorrhage: State of the art and future perspectives.

  Grasso G, Alafaci C, Macdonald RL. Grasso G, et al. Surg Neurol Int. 2017 Jan 19;8:11. doi: 10.4103/2152-7806.198738. eCollection 2017. Surg Neurol Int. 2017. PMID: 28217390 Free PMC article. Review.
• Cerebral Vasospasm in Critically III Patients with Aneurysmal Subarachnoid Hemorrhage: Does the Evidence Support the Ever-Growing List of Potential Pharmacotherapy Interventions?

  Kiser TH. Kiser TH. Hosp Pharm. 2014 Nov;49(10):923-41. doi: 10.1310/hpj4910-923. Hosp Pharm. 2014. PMID: 25477565 Free PMC article.
• Off-label use of drugs and devices in the neuroendovascular suite.

  Abdihalim MM, Hassan AE, Qureshi AI. Abdihalim MM, et al. AJNR Am J Neuroradiol. 2013 Nov-Dec;34(11):2054-63. doi: 10.3174/ajnr.A3447. Epub 2013 Mar 21. AJNR Am J Neuroradiol. 2013. PMID: 23518356 Free PMC article. Review.
• Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's Multidisciplinary Consensus Conference.

  Diringer MN, Bleck TP, Claude Hemphill J 3rd, Menon D, Shutter L, Vespa P, Bruder N, Connolly ES Jr, Citerio G, Gress D, Hänggi D, Hoh BL, Lanzino G, Le Roux P, Rabinstein A, Schmutzhard E, Stocchetti N, Suarez JI, Treggiari M, Tseng MY, Vergouwen MD, Wolf S, Zipfel G; Neurocritical Care Society. Diringer MN, et al. Neurocrit Care. 2011 Sep;15(2):211-40. doi: 10.1007/s12028-011-9605-9. Neurocrit Care. 2011. PMID: 21773873 Review.